Radioembolization for Advanced Hepatocellular Carcinoma

被引:0
|
作者
Ertle, Judith [1 ]
Gerken, Guido [1 ]
Schlaak, Joerg F. [1 ]
机构
[1] Univ Klinikum Essen, Lebertumorctr Essen, Klin Gastroenterol & Hepatol, D-45147 Essen, Germany
来源
VISZERALMEDIZIN | 2012年 / 28卷 / 05期
关键词
Hepatocellular carcinoma; HCC; Local ablative therapy; Radioembolization; Selective intraarterial radiotherapy; SIRT; Transarterial chemoembolization; TACE; Downstaging; Bridging; LIVER-TRANSPLANTATION; MICROSPHERES; SURVIVAL; CANCER; CHEMOEMBOLIZATION; SORAFENIB; REDUCTION; THERAPY;
D O I
10.1159/000343786
中图分类号
R61 [外科手术学];
学科分类号
摘要
Radioembolization for Advanced Hepatocellular Carcinoma Background: Hepatocellular carcinoma (HCC) is the sixth most common tumor worldwide with a rising incidence in the western world. Most patients are diagnosed at an advanced stage, in which curative treatments are not feasible any more. Method: Literature review. Results: Selective intraarterial radiotherapy (SIRT) is one new option of local ablative treatment of HCC. Radioactive microspheres (Yttrium-90) are applied to the liver via intraarterial catheter. The distribution of the spheres depends on the arterial blood flow; therefore, the microspheres are mainly distributed to arterial hypervascular tumors such as HCC. Arterial hypervascularity is one of the most important conditions to perform SIRT. Studies in advanced HCC, even with underlying portal vein thrombosis, showed its safety and efficiency. Studies even demonstrate efficiency in downstaging and bridging to transplantation by SIRT. Median overall survival was approximately 16 months in several studies. Conclusions: Randomized studies in comparison with the standard treatments as established in the guidelines (transarterial chemoembolization in intermediate stages; sorafenib in advanced stages) are not available yet; therefore, SIRT is not included in these guidelines. Studies to prove its significance in treating HCC need to be carried out. However, future treatment of HCC will also include personalized therapies and combinations of systemic and local ablative therapies.
引用
收藏
页码:311 / 316
页数:6
相关论文
共 50 条
  • [1] Radioembolization in Advanced Hepatocellular Carcinoma
    Riaz, Ahsun
    Lewandowski, Robert
    Salem, Riad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1898 - +
  • [2] Transarterial Radioembolization in Advanced Stage Hepatocellular Carcinoma
    Yang, Ju Dong
    Harmsen, William S.
    Slettedahl, Seth W.
    Enders, Felicity
    Therneau, Terry M.
    Roberts, Lewis R.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S913 - S913
  • [3] Radioembolization for hepatocellular carcinoma
    Sangro, Bruno
    Inarrairaegui, Mercedes
    Bilbao, Jose I.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 (02) : 464 - 473
  • [4] Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular Carcinoma
    Yeo, Yee Hui
    Liang, Jeff
    Lauzon, Marie
    Luu, Michael
    Noureddin, Mazen
    Ayoub, Walid
    Kuo, Alexander
    Sankar, Kamya
    Gong, Jun
    Hendifar, Andrew
    Osipov, Arsen
    Friedman, Marc L.
    Lipshutz, H. Gabriel
    Steinberger, Jonathan
    Kosari, Kambiz
    Nissen, Nicholas
    Abou-Alfa, Ghassan K.
    Singal, Amit G.
    Yang, Ju Dong
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12): : 2201 - 2211
  • [5] Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
    Lee, Victor Ho-Fun
    Leung, Dennis K. C.
    Luk, Mai-Yee
    Tong, Chi-Chung
    Law, Martin W. M.
    Ng, Sherry C. Y.
    Wong, Ka-Kin
    Poon, Ronnie T. P.
    Kwong, Dora L. W.
    Leung, To-Wai
    [J]. ONCOTARGETS AND THERAPY, 2015, 8 : 3457 - 3464
  • [6] Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium
    Raphaël Girardet
    Sarah Boughdad
    Antonia Digklia
    Catherine Beigelman
    Marie Meyer
    Niklaus Schaefer
    Mathilde Vermersch
    Arnaud Hocquelet
    Georgia Tsoumakidou
    Alban Denys
    Rafael Duran
    [J]. CardioVascular and Interventional Radiology, 2020, 43 : 1712 - 1715
  • [7] Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium
    Girardet, Raphael
    Boughdad, Sarah
    Digklia, Antonia
    Beigelman, Catherine
    Meyer, Marie
    Schaefer, Niklaus
    Vermersch, Mathilde
    Hocquelet, Arnaud
    Tsoumakidou, Georgia
    Denys, Alban
    Duran, Rafael
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 43 (11) : 1712 - 1715
  • [8] Lobar Radioembolization for Intermediate and Advanced Hepatocellular Carcinoma: Retrospective and Prospective Data
    Lakhoo, Janesh
    Perez, Thomas H.
    Borgmann, Anthony J.
    Brown, Daniel B.
    [J]. SEMINARS IN INTERVENTIONAL RADIOLOGY, 2021, 38 (04) : 412 - 418
  • [9] RADIOEMBOLIZATION WITH YTTRIUM-90 FOR ADVANCED HEPATOCELLULAR CARCINOMA: A CANADIAN EXPERIENCE
    Montano-Loza, A. J.
    Purdy, D.
    Bain, V. G.
    Meza-Junco, J.
    Ma, M.
    Wong, W. W. S.
    Owen, R.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S112 - S112
  • [10] Chemoembolization and Radioembolization for Hepatocellular Carcinoma
    Salem, Riad
    Lewandowski, Robert J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (06) : 604 - 611